Φορτώνει......
A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in humans. Despite several emerging vaccines, there remains no verifiable therapeutic targeted specifically to the virus. Here we present a highly effective siRNA therapeutic again...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | bioRxiv |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Cold Spring Harbor Laboratory
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8077569/ https://ncbi.nlm.nih.gov/pubmed/33907744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.19.440531 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|